CA2554480C - Test element and method for testing blood - Google Patents
Test element and method for testing blood Download PDFInfo
- Publication number
- CA2554480C CA2554480C CA2554480A CA2554480A CA2554480C CA 2554480 C CA2554480 C CA 2554480C CA 2554480 A CA2554480 A CA 2554480A CA 2554480 A CA2554480 A CA 2554480A CA 2554480 C CA2554480 C CA 2554480C
- Authority
- CA
- Canada
- Prior art keywords
- test
- blood
- test element
- bag
- testing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/508—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5023—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures with a sample being transported to, and subsequently stored in an absorbent for analysis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
Abstract
Test element for diagnostic tests, in particular for testing blood before a transfusion, wherein the test element comprises two test units for performing at least two tests, and wherein the test element comprises a fixing means for the fixation of the test element.
Description
Test element and method for testing blood The invention relates to a test element and a method for diagnostic tests, in par-ticular for testing of bag and receptor blood before a blood transfusion.
One of the greatest risks regarding transfusions of blood constituents, so-called blood transfusions, is a blood-group incompatibility between bag and receptor blood. The reasons for this are more often mix-ups than false determinations.
For these reasons, so-called ABO identity tests are compulsory in some countries, which are carried out by the treating personnel, e.g. the nurse or the transfusing doctor, immediately before the transfusion at the patient's bed. These tests lead to additional stress of the station personnel which have little training in lab diagnos-tics and are amongst others rejected for this reason in some countries.
In certain countries as for example Germany or Austria, such an identity test is compulsory, however, only with regard to the receptor blood. In these countries, it is left to the respective hospital whether it carries out the identity test of the bag at the patient's bed or not. This is justified with the responsibility of the producer (blood bank) for the correct determination and designation of the bag blood.
However, this does not prevent many hospitals from checking the bag blood type in the hospital lab once more and/or to carry out an ABO identity test at the pa-tient's bed.
The object of the present invention is to practically eliminate the risk of mixing up during a blood transfusion without increasing the effort. Moreover, the costs for the blood transfusion shall not increase thereby.
In accordance with the invention, there is provided a method for testing blood during the preparation and performance of bedside-tests, wherein the method comprises the following steps:
One of the greatest risks regarding transfusions of blood constituents, so-called blood transfusions, is a blood-group incompatibility between bag and receptor blood. The reasons for this are more often mix-ups than false determinations.
For these reasons, so-called ABO identity tests are compulsory in some countries, which are carried out by the treating personnel, e.g. the nurse or the transfusing doctor, immediately before the transfusion at the patient's bed. These tests lead to additional stress of the station personnel which have little training in lab diagnos-tics and are amongst others rejected for this reason in some countries.
In certain countries as for example Germany or Austria, such an identity test is compulsory, however, only with regard to the receptor blood. In these countries, it is left to the respective hospital whether it carries out the identity test of the bag at the patient's bed or not. This is justified with the responsibility of the producer (blood bank) for the correct determination and designation of the bag blood.
However, this does not prevent many hospitals from checking the bag blood type in the hospital lab once more and/or to carry out an ABO identity test at the pa-tient's bed.
The object of the present invention is to practically eliminate the risk of mixing up during a blood transfusion without increasing the effort. Moreover, the costs for the blood transfusion shall not increase thereby.
In accordance with the invention, there is provided a method for testing blood during the preparation and performance of bedside-tests, wherein the method comprises the following steps:
at first - testing of blood of a blood bag (12) by means of a first test unit (2) of a test element (1), preferably in the hospital laboratory; and subsequently - fixing the test element (1) at the blood bag (12) containing the bag blood by means of a fixing means (4);
and thereafter - testing the blood of the recipient by means of a second test unit (3) of the test element (1), preferably at the bed of the patient.
By means of such a test element, the danger of mixing up a blood bag and thus the application of blood with non-compatible blood type during a blood transfusion may practically be excluded. Preferably, by means of one of the at least two test units of the test element, the bag blood is tested for the blood transfusion, in other words the blood of a segment of the blood bag. Thereby, the test element is formed in such a way that the result of the test may be read off after a short period of time without any additional aids.
By means of the inventive fixing element, the complete test element may be fixed at the respective blood bag. Thereby, everybody can see that at this blood bag a confirming blood-type test has been carried out and which result this blood-type test provides. Further, by using the inventive test element, the confirming test may be carried out with few manual steps and in a short period of time.
Additionally, the inventive test element comprises the advantage that further mistakes, as e.g.
scribal errors, may practically be excluded.
In a preferred embodiment of the invention, bonding foil or cable binders are used as fixing elements.
The second inventive test unit of the test element is preferably used to further re-3o duce the danger of application of a blood bag with unsuitable blood type.
To this end, the blood of the receptor of the blood transfusion is preferably tested imme-diately before the transfusion by means of the second test unit of the test element.
The aids being necessary therefor, namely the test element, are physically con-nected with the blood bag and is thus inevitably provided at the patient's bed.
Preferably, the two test units of the test element are arranged in such a way that, after performing both tests, it is easy to recognize whether the blood type of the blood bag matches with the blood type of the receptor or not. This is achieved preferably by a laterally reversed arrangement of the test chambers - for fluid in-dicator reagents - or the test fields - for immobilized indicator reagents -of the test units.
In a further preferred embodiment, in at least at one test unit the test result in the test is maintained as long and thus visible as the bag is applicable according to the manufacturer information, for example 45 days so that the test element may also be used for record reasons and for supervision. The indication of the test result, in particular the test result regarding the blood type in the blood bag, remains pref-erably visible during the shelf-life, for example 45 days, when stored at 2 C
to 8 C in order that the tested blood bag may be kept in a bag cooling device for this duration of time, before it is used for the blood transfusion. When using a fluid reagent as indicator reagent, this preservability may e.g. be achieved in that cell stabilizers are added to the fluid reagent.
If fluid indicator reagents shall be used, in a further preferred embodiment at least one of the test units for carrying out the tests is formed in such a way that the test chamber for receiving the indicator reagent is closed or closable and after the per-formance of the test, no fluid emerges therefrom, i.e. by evaporation, so that in the case of reactions in the fluid phase, the test unit does not dry out and thereby the test carried out at the patient may be compared with the test carried out at the blood bag later on. To this end, for example suitable closing mechanisms may be applied.
and thereafter - testing the blood of the recipient by means of a second test unit (3) of the test element (1), preferably at the bed of the patient.
By means of such a test element, the danger of mixing up a blood bag and thus the application of blood with non-compatible blood type during a blood transfusion may practically be excluded. Preferably, by means of one of the at least two test units of the test element, the bag blood is tested for the blood transfusion, in other words the blood of a segment of the blood bag. Thereby, the test element is formed in such a way that the result of the test may be read off after a short period of time without any additional aids.
By means of the inventive fixing element, the complete test element may be fixed at the respective blood bag. Thereby, everybody can see that at this blood bag a confirming blood-type test has been carried out and which result this blood-type test provides. Further, by using the inventive test element, the confirming test may be carried out with few manual steps and in a short period of time.
Additionally, the inventive test element comprises the advantage that further mistakes, as e.g.
scribal errors, may practically be excluded.
In a preferred embodiment of the invention, bonding foil or cable binders are used as fixing elements.
The second inventive test unit of the test element is preferably used to further re-3o duce the danger of application of a blood bag with unsuitable blood type.
To this end, the blood of the receptor of the blood transfusion is preferably tested imme-diately before the transfusion by means of the second test unit of the test element.
The aids being necessary therefor, namely the test element, are physically con-nected with the blood bag and is thus inevitably provided at the patient's bed.
Preferably, the two test units of the test element are arranged in such a way that, after performing both tests, it is easy to recognize whether the blood type of the blood bag matches with the blood type of the receptor or not. This is achieved preferably by a laterally reversed arrangement of the test chambers - for fluid in-dicator reagents - or the test fields - for immobilized indicator reagents -of the test units.
In a further preferred embodiment, in at least at one test unit the test result in the test is maintained as long and thus visible as the bag is applicable according to the manufacturer information, for example 45 days so that the test element may also be used for record reasons and for supervision. The indication of the test result, in particular the test result regarding the blood type in the blood bag, remains pref-erably visible during the shelf-life, for example 45 days, when stored at 2 C
to 8 C in order that the tested blood bag may be kept in a bag cooling device for this duration of time, before it is used for the blood transfusion. When using a fluid reagent as indicator reagent, this preservability may e.g. be achieved in that cell stabilizers are added to the fluid reagent.
If fluid indicator reagents shall be used, in a further preferred embodiment at least one of the test units for carrying out the tests is formed in such a way that the test chamber for receiving the indicator reagent is closed or closable and after the per-formance of the test, no fluid emerges therefrom, i.e. by evaporation, so that in the case of reactions in the fluid phase, the test unit does not dry out and thereby the test carried out at the patient may be compared with the test carried out at the blood bag later on. To this end, for example suitable closing mechanisms may be applied.
In a further preferred embodiment the test unit for the bag blood comprises at least three test chambers or test fields, in which respectively an anti-A, an anti-B, and an anti-D reagent is contained. By means of these at least three test chambers re-spectively test fields, an ABD test may accordingly be carried out. In a further preferred embodiment, a further test chamber respectively a further test field for carrying out self-control is provided. The test unit for the blood of the receptor comprises preferably at least two test chambers respectively two test fields, in which preferably an anti-A and an anti-B reagent is contained. By means of these at least two test chambers respectively test fields, an ABO test may be carried out.
According to the invention, this object is solved also by a method for testing blood during the preparation and performance of blood transfusions, wherein the method comprises the steps of:
- testing the bag blood by means of the first test unit in a test element, as de-scribed above, preferably in the hospital lab, - fixing the test element at the blood bag containing the bag blood by means of a fixing means, and testing the blood of the receptor by means of a second test unit of the test element, preferably at the patient's bed, in particular within 45 days after testing the bag blood.
The inventive method for testing blood comprises the advantage that an applica-tion of a blood bag with a blood type being incompatible for the patient may prac-tically be excluded during blood transfusion. By the application of a test element, which may be fixed to the blood bag for testing the bag blood and the blood of the receptor, a mix-up is practically impossible, since it is clearly visible which tests have already been carried out for the blood transfusion, in which the blood bag shall be applied and what the result of the respective tests was. The nurse who is rather untrained in diagnostic tests is provided with a reference result through the real result of the lab test being visible for her in situ, which facilitates for her the evaluation whether her own result is correct. This saves time-consuming inquiries at the hospital lab.
In addition, the nurse is substantially disburdened by blood bag testing in the lab.
Further, the inventive method enables that the blood bags are clearly marked and thus no records have to be checked.
Preferably, this method is used for testing blood types. Further preferred it is veri-fied before the performance of the blood transfusion that during testing of the bag blood and during testing of the receptor blood the same blood type has been iden-tified.
In the following, an exemplary embodiment of the invention is illustrated by means of the attached drawings, in which Fig. 1 shows a plan view of a preferred embodiment of an inventive test element, Fig. 2 shows a plan view of a further preferred embodiment of an inventive test element, and Fig. 3 shows an example for the fixation of the test element at a blood bag.
Fig. 1 shows a test element 1 with a test unit 2 for testing the bag blood and a test unit 3 for testing the receptor blood. An example for such a test element is de-scribed in the international patent application PCT/EP 03/10590 of the applicant.
Each test unit 2, 3 comprises its own inlet 5, 6 for the fluid to be tested.
In the illustrated example, Luer Lok inlets are considered to which e.g. syringes may be connected.
According to the invention, this object is solved also by a method for testing blood during the preparation and performance of blood transfusions, wherein the method comprises the steps of:
- testing the bag blood by means of the first test unit in a test element, as de-scribed above, preferably in the hospital lab, - fixing the test element at the blood bag containing the bag blood by means of a fixing means, and testing the blood of the receptor by means of a second test unit of the test element, preferably at the patient's bed, in particular within 45 days after testing the bag blood.
The inventive method for testing blood comprises the advantage that an applica-tion of a blood bag with a blood type being incompatible for the patient may prac-tically be excluded during blood transfusion. By the application of a test element, which may be fixed to the blood bag for testing the bag blood and the blood of the receptor, a mix-up is practically impossible, since it is clearly visible which tests have already been carried out for the blood transfusion, in which the blood bag shall be applied and what the result of the respective tests was. The nurse who is rather untrained in diagnostic tests is provided with a reference result through the real result of the lab test being visible for her in situ, which facilitates for her the evaluation whether her own result is correct. This saves time-consuming inquiries at the hospital lab.
In addition, the nurse is substantially disburdened by blood bag testing in the lab.
Further, the inventive method enables that the blood bags are clearly marked and thus no records have to be checked.
Preferably, this method is used for testing blood types. Further preferred it is veri-fied before the performance of the blood transfusion that during testing of the bag blood and during testing of the receptor blood the same blood type has been iden-tified.
In the following, an exemplary embodiment of the invention is illustrated by means of the attached drawings, in which Fig. 1 shows a plan view of a preferred embodiment of an inventive test element, Fig. 2 shows a plan view of a further preferred embodiment of an inventive test element, and Fig. 3 shows an example for the fixation of the test element at a blood bag.
Fig. 1 shows a test element 1 with a test unit 2 for testing the bag blood and a test unit 3 for testing the receptor blood. An example for such a test element is de-scribed in the international patent application PCT/EP 03/10590 of the applicant.
Each test unit 2, 3 comprises its own inlet 5, 6 for the fluid to be tested.
In the illustrated example, Luer Lok inlets are considered to which e.g. syringes may be connected.
In the test unit 2 for the bag blood, three channels 7, 8, 9 begin at the inlet 5, through which the fluid to be tested, preferably blood, flows to the reaction cham-bers 21, 22, 23. In the embodiment illustrated in fig. 1, the first chamber 21 com-prises an anti-A reagent, the second chamber 22 an anti-B reagent, and the third chamber 23 an anti-D reagent. By means of this test unit, the information on the blood bag is verified.
In the embodiment shown in fig. 1, the second test unit 3 comprises for the testing of the blood of the receptor two channels 10, 11, through which the fluid to be tested flows from the inlet 6 to the reaction chambers 31, 32. In order to carry out an ABO test with this test unit 3, one reaction chamber 31 comprises an anti-A
reagent and the other reaction chamber an anti-B reagent. In the present exem-plary embodiment, the chambers of the two test units with the same contents are arranged laterally reversed, in order to facilitate a comparison of the two test re-sults.
Fig. 1 provides reaction chambers for the application of fluid reagents.
Fig. 2 shows another embodiment of the inventive test element, which is suitable for immobilized reagents. The test element 1 is also in this case divided into two test units 2, 3. The test units 2, 3 comprise two, respectively three test fields 21', 22', 23' respectively 31', 32' corresponding to the test chambers with the same reference signs without apostrophe in fig. 1. In these test fields, the indicator rea-gents being necessary for the test are immobilized in a suitable way, i.e.
bound.
The blood is applied to the test fields 21', 22', 23' respectively 31', 32' via sur-faces 5', respectively 6' for applying the blood and via supplying surfaces 7', 8', 9' respectively 10', 11' - for example porous separation membranes for example of nitro cellulose in which blood is movable, corresponding to the channels with respective reference signs without apostrophe in fig. 1. The test element illustrated here is formed in such a way that the supplying surfaces 7', 8', 9' respectively 10', 11' are arranged in one plane beneath the surface of the test element 1.
When the blood reaches the test fields 21', 22', 23' respectively 31', 32' which are sepa-rated from the surface of the test element I by a layer being at least transparent in the area of a window, a reaction occurs with the indicator reagents. This reaction may be monitored through the transparent area of the covering of the test fields.
Examples for such a test unit are contained in the German patent application publication no. DE 103 30 982 Al.
Figure 3 shows a test element 1 which has been fixed to a blood bag 12 by means of fixing means 4, wherein the fixing means is preferably pre-associated with the test means.
Preferably, the fixing means 4 consists of a bonding strip on the backside of the test element 1. This bonding strip may be self-bonding and may be covered before the application with a releasable covering band.
The fixing means 4 may also consist of an engagement equipment, which may engage in a corresponding counterpart on a blood bag 12, in such a way that it is no longer removable or only by means of a tool - for example a key.
In the embodiment shown in fig. 1, the second test unit 3 comprises for the testing of the blood of the receptor two channels 10, 11, through which the fluid to be tested flows from the inlet 6 to the reaction chambers 31, 32. In order to carry out an ABO test with this test unit 3, one reaction chamber 31 comprises an anti-A
reagent and the other reaction chamber an anti-B reagent. In the present exem-plary embodiment, the chambers of the two test units with the same contents are arranged laterally reversed, in order to facilitate a comparison of the two test re-sults.
Fig. 1 provides reaction chambers for the application of fluid reagents.
Fig. 2 shows another embodiment of the inventive test element, which is suitable for immobilized reagents. The test element 1 is also in this case divided into two test units 2, 3. The test units 2, 3 comprise two, respectively three test fields 21', 22', 23' respectively 31', 32' corresponding to the test chambers with the same reference signs without apostrophe in fig. 1. In these test fields, the indicator rea-gents being necessary for the test are immobilized in a suitable way, i.e.
bound.
The blood is applied to the test fields 21', 22', 23' respectively 31', 32' via sur-faces 5', respectively 6' for applying the blood and via supplying surfaces 7', 8', 9' respectively 10', 11' - for example porous separation membranes for example of nitro cellulose in which blood is movable, corresponding to the channels with respective reference signs without apostrophe in fig. 1. The test element illustrated here is formed in such a way that the supplying surfaces 7', 8', 9' respectively 10', 11' are arranged in one plane beneath the surface of the test element 1.
When the blood reaches the test fields 21', 22', 23' respectively 31', 32' which are sepa-rated from the surface of the test element I by a layer being at least transparent in the area of a window, a reaction occurs with the indicator reagents. This reaction may be monitored through the transparent area of the covering of the test fields.
Examples for such a test unit are contained in the German patent application publication no. DE 103 30 982 Al.
Figure 3 shows a test element 1 which has been fixed to a blood bag 12 by means of fixing means 4, wherein the fixing means is preferably pre-associated with the test means.
Preferably, the fixing means 4 consists of a bonding strip on the backside of the test element 1. This bonding strip may be self-bonding and may be covered before the application with a releasable covering band.
The fixing means 4 may also consist of an engagement equipment, which may engage in a corresponding counterpart on a blood bag 12, in such a way that it is no longer removable or only by means of a tool - for example a key.
Claims (15)
1. Method for testing blood during the preparation and performance of bedside-tests, wherein the method comprises the following steps:
at first - testing of blood of a blood bag (12) by means of a first test unit (2) of a test element (1); and subsequently - fixing the test element (1) at the blood bag (12) containing the bag blood by means of a fixing means (4);
and thereafter - testing the blood of a recipient by means of a second test unit (3) of the test element (1).
at first - testing of blood of a blood bag (12) by means of a first test unit (2) of a test element (1); and subsequently - fixing the test element (1) at the blood bag (12) containing the bag blood by means of a fixing means (4);
and thereafter - testing the blood of a recipient by means of a second test unit (3) of the test element (1).
2. Method according to claim 1, characterized in that, after the testing of the bag blood and after the testing of the recipient blood, the test results are compared.
3. Method as claimed in claim 1 or 2, wherein the testing of a blood bag (12) by means of a first test unit (2) of a test element (1) is conducted in a hospital laboratory.
4. Method according to claim 1, 2 or 3, wherein the testing of the blood of a recipient by means of a second test unit (3) and the test element (1) is conducted at a bed of a patient.
5. Test element (1) for carrying out the method according to claim 1, wherein the test element (1) comprises at least said first test unit (2) and said second test unit (3) for performing at least two tests, and the test element (1) comprises said fixing means (4) for fixing the test element (1) at the blood bag.
6. Test element (1) according to claim 5, characterized in that the fixing means (4) is provided as a bonding foil.
7. Test element (1) according to claim 5, characterized in that the fixing means (4) is provided as a cable tie.
8. Test element (1) according to any one of claims 5 to 7, characterized in that at least one of the first and second test units (2, 3) comprises a suitable closing mechanism such that, after the performance of the tests no fluid emerges.
9. Test element (1) according to any one of claims 5 to 8, characterized in that by means of one of the at least first and second test units (2, 3) bag blood for blood transfusions can be tested.
10. Test element (1) according to claim 9, characterized in that the first test unit (2) for bag blood comprises at least three test chambers (21, 22, 23) or test fields (21', 22', 23').
11. Test element (1) according to claim 10, characterized in that the at least three test chambers (21, 22, 23) or test fields (21', 22', 23') respectively comprise anti-A, anti-B, and anti-D reagents.
12. Test element (1) according to any one of claims 5 to 11, characterized in that by means of the second test unit (3), the blood of a recipient of a blood transfusion can be tested.
13. Test element (1) according to claim 12, characterized in that the second test unit (3) for the blood of a recipient comprises at least two test chambers (31, 32) or test fields (31', 32').
14. Test element (1) according to claim 13, characterized in that the at least two test chambers (31, 32) or test fields (31', 32') respectively contain anti-A and anti-B reagents.
15. Test element (1) according to any one of claims 5 to 14, characterized in that in at least one of the first and second test units (2, 3) the test result is maintained at least 45 days by adding cell stabilizers to the reagents.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004005139.9 | 2004-02-02 | ||
| DE102004005139A DE102004005139A1 (en) | 2004-02-02 | 2004-02-02 | Test element and method for testing blood |
| PCT/EP2005/001027 WO2005072876A1 (en) | 2004-02-02 | 2005-02-02 | Test element and method for testing blood |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2554480A1 CA2554480A1 (en) | 2005-08-11 |
| CA2554480C true CA2554480C (en) | 2012-01-10 |
Family
ID=34801453
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2554480A Expired - Fee Related CA2554480C (en) | 2004-02-02 | 2005-02-02 | Test element and method for testing blood |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US7871825B2 (en) |
| EP (1) | EP1713589B1 (en) |
| JP (1) | JP4782697B2 (en) |
| KR (1) | KR101051445B1 (en) |
| CN (1) | CN100515570C (en) |
| AT (1) | ATE481171T1 (en) |
| AU (1) | AU2005209072B2 (en) |
| BR (1) | BRPI0507339A (en) |
| CA (1) | CA2554480C (en) |
| DE (2) | DE102004005139A1 (en) |
| EG (1) | EG24879A (en) |
| ES (1) | ES2352678T3 (en) |
| IL (1) | IL177144A (en) |
| MX (1) | MXPA06008701A (en) |
| NZ (1) | NZ548800A (en) |
| PT (1) | PT1713589E (en) |
| RU (1) | RU2364443C2 (en) |
| WO (1) | WO2005072876A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120016685A1 (en) * | 2010-07-13 | 2012-01-19 | Cerner Innovation, Inc. | Blood management for outpatient procedures |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL89406C (en) | 1951-07-28 | |||
| GB1095429A (en) * | 1965-05-17 | |||
| US3502437A (en) * | 1967-03-13 | 1970-03-24 | Haematronics Inc | Identification card |
| US4164320A (en) * | 1974-09-26 | 1979-08-14 | Medical Laboratory Automation, Inc. | Patient and specimen identification means and system employing same |
| US3990850A (en) * | 1976-01-06 | 1976-11-09 | Akzona Incorporated | Diagnostic test card |
| US4055394A (en) * | 1976-10-18 | 1977-10-25 | Akzona Incorporated | Diagnostic test card |
| DE8029596U1 (en) | 1980-11-06 | 1981-06-11 | Biotest-Serum-Institut Gmbh, 6000 Frankfurt | BLOOD GROUP IDENTITY CARD, ESPECIALLY FOR THE BED SIDE TEST |
| JPS5975153A (en) * | 1982-09-22 | 1984-04-27 | オ−ソ・ダイアグノステイツク・システムズ・インコ−ポレ−テツド | Test kit for abo blood transfusion adaptation |
| US4650662A (en) * | 1984-11-13 | 1987-03-17 | Cedars-Sinai Medical Center | Portable blood typing apparatus and method |
| US4906439A (en) * | 1986-03-25 | 1990-03-06 | Pb Diagnostic Systems, Inc. | Biological diagnostic device and method of use |
| US4851210A (en) | 1986-05-22 | 1989-07-25 | Genelabs Incorporated | Blood typing device |
| US4900321A (en) * | 1986-12-12 | 1990-02-13 | Baxter International Inc. | Set with integrally formed sample cell |
| US5287264A (en) * | 1988-08-05 | 1994-02-15 | Hitachi, Ltd. | Multicontroller apparatus, multicontroller system, nuclear reactor protection system, inverter control system and diagnostic device |
| JPH0774772B2 (en) | 1990-12-31 | 1995-08-09 | エイ． レビン ロバート | Blood sampling assembly, target cell collection method and target component collection method |
| DE4313253A1 (en) | 1993-04-23 | 1994-10-27 | Boehringer Mannheim Gmbh | System for analyzing the contents of liquid samples |
| EP0638364B1 (en) | 1993-08-03 | 1999-06-16 | Erich Dr. Baumgärtner | Test device |
| US5429119A (en) * | 1993-09-03 | 1995-07-04 | Welch Allyn, Inc. | Hand-held compact diagnostic device |
| EP0741296A1 (en) | 1995-05-05 | 1996-11-06 | Institut Jacques Boy | Pretransfusion control card for the determination of compatibility between donor and receiver blood |
| FR2742544B1 (en) | 1995-12-13 | 1998-02-13 | Lider Sarl | METHOD FOR VISUAL CONTROL OF A LIQUID BY MIXING WITH A REACTIVE LIQUID AND DEVICE FOR IMPLEMENTING SAME |
| IL120120A (en) | 1996-02-02 | 2001-10-31 | Ortho Diagnostic Systems Inc | Vessel for conducting blood cell agglutination |
| DE19640904A1 (en) | 1996-10-04 | 1998-04-09 | Andreas Kahle | Skin test strips |
| JP3407566B2 (en) * | 1996-11-05 | 2003-05-19 | 日産自動車株式会社 | Diagnosis device for evaporative fuel treatment equipment |
| JP3428426B2 (en) | 1997-03-26 | 2003-07-22 | 株式会社日立製作所 | Sample analysis system |
| AU8294698A (en) * | 1998-05-01 | 1999-11-23 | Aalto Scientific, Ltd. | Integrated body fluid collection and analysis device with sample transfer component |
| US7112175B2 (en) * | 1998-05-26 | 2006-09-26 | Ineedmd.Com | Tele-diagnostic device |
| DE19834218A1 (en) | 1998-07-29 | 2000-02-03 | Heuft Systemtechnik Gmbh | Procedure for checking closed containers |
| RU2147123C1 (en) | 1998-12-16 | 2000-03-27 | Боев Сергей Федотович | Method for examining cellular blood composition using a smear |
| IL130818A (en) * | 1999-07-06 | 2005-07-25 | Intercure Ltd | Interventive-diagnostic device |
| JP2001056341A (en) * | 1999-08-20 | 2001-02-27 | Wako Pure Chem Ind Ltd | Blood grouping method |
| JP3672783B2 (en) * | 1999-12-15 | 2005-07-20 | 寺田 智子 | Blood product verification system for transfusion |
| IL135275A0 (en) | 2000-03-27 | 2001-05-20 | Shapira Hagit | Blood transfusion method and device |
| FR2842297B1 (en) * | 2002-07-09 | 2004-09-03 | Actaris Sas | FLUID VOLUMETRIC COUNTER |
| DE20215268U1 (en) | 2002-10-02 | 2003-04-17 | Euroimmun Ag | Self-adhesive blotting membrane, useful in nucleic acid hybridization and immunoassay diagnostic tests, has reversible adhesive on the back face |
-
2004
- 2004-02-02 DE DE102004005139A patent/DE102004005139A1/en not_active Ceased
-
2005
- 2005-02-02 DE DE502005010259T patent/DE502005010259D1/en active Active
- 2005-02-02 RU RU2006127250/04A patent/RU2364443C2/en not_active IP Right Cessation
- 2005-02-02 CN CNB2005800037734A patent/CN100515570C/en not_active Expired - Fee Related
- 2005-02-02 NZ NZ548800A patent/NZ548800A/en not_active IP Right Cessation
- 2005-02-02 AU AU2005209072A patent/AU2005209072B2/en not_active Ceased
- 2005-02-02 US US10/588,053 patent/US7871825B2/en not_active Expired - Fee Related
- 2005-02-02 PT PT05701309T patent/PT1713589E/en unknown
- 2005-02-02 EP EP05701309A patent/EP1713589B1/en not_active Not-in-force
- 2005-02-02 KR KR1020067015679A patent/KR101051445B1/en not_active IP Right Cessation
- 2005-02-02 BR BRPI0507339-1A patent/BRPI0507339A/en not_active IP Right Cessation
- 2005-02-02 MX MXPA06008701A patent/MXPA06008701A/en active IP Right Grant
- 2005-02-02 JP JP2006550145A patent/JP4782697B2/en not_active Expired - Fee Related
- 2005-02-02 ES ES05701309T patent/ES2352678T3/en active Active
- 2005-02-02 AT AT05701309T patent/ATE481171T1/en active
- 2005-02-02 WO PCT/EP2005/001027 patent/WO2005072876A1/en active Application Filing
- 2005-02-02 CA CA2554480A patent/CA2554480C/en not_active Expired - Fee Related
-
2006
- 2006-07-27 IL IL177144A patent/IL177144A/en not_active IP Right Cessation
- 2006-08-01 EG EGNA2006000721 patent/EG24879A/en active
Also Published As
| Publication number | Publication date |
|---|---|
| DE102004005139A1 (en) | 2005-08-18 |
| BRPI0507339A (en) | 2007-07-03 |
| EP1713589B1 (en) | 2010-09-15 |
| IL177144A (en) | 2011-05-31 |
| PT1713589E (en) | 2010-12-06 |
| ATE481171T1 (en) | 2010-10-15 |
| US20070218557A1 (en) | 2007-09-20 |
| EP1713589A1 (en) | 2006-10-25 |
| JP2007519911A (en) | 2007-07-19 |
| MXPA06008701A (en) | 2007-01-23 |
| AU2005209072A1 (en) | 2005-08-11 |
| RU2364443C2 (en) | 2009-08-20 |
| IL177144A0 (en) | 2006-12-10 |
| EG24879A (en) | 2010-12-01 |
| DE502005010259D1 (en) | 2010-10-28 |
| RU2006127250A (en) | 2008-03-10 |
| KR101051445B1 (en) | 2011-07-22 |
| WO2005072876A1 (en) | 2005-08-11 |
| JP4782697B2 (en) | 2011-09-28 |
| AU2005209072B2 (en) | 2009-09-17 |
| CN100515570C (en) | 2009-07-22 |
| CN1960806A (en) | 2007-05-09 |
| US7871825B2 (en) | 2011-01-18 |
| CA2554480A1 (en) | 2005-08-11 |
| KR20070006740A (en) | 2007-01-11 |
| NZ548800A (en) | 2010-12-24 |
| ES2352678T3 (en) | 2011-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6033914A (en) | Electrochemical analytical cartridge | |
| US5919711A (en) | Analytical cartridge | |
| US10670614B2 (en) | Hemolysis detection device, system and method | |
| EP2788774B1 (en) | Method and device for assaying an antigen present on erythrocytes or an antibody binding to an antigen present on erythrocytes | |
| CN101091115A (en) | Assay system | |
| CN104107561A (en) | Biological fluid separation device, and biological fluid separation and testing system | |
| CA2554480C (en) | Test element and method for testing blood | |
| WO2014025401A1 (en) | Kits and methods for determining physiologic level(s) and/or range(s) of hemoglobin and/or disease state | |
| Alwar et al. | Evaluation of the use of gel card system for assessment of direct coombs test: weighing the pros and cons | |
| JP2007519911A5 (en) | ||
| US4708850A (en) | Self-contained portable apparatus for blood typing | |
| DE102012014922A1 (en) | Test- and result releasing method in diagnostic system, comprises processing sample, determining genetic information, and generating diagnostic results | |
| Wright et al. | Laboratory investigation of autoimmune hemolytic anemias | |
| US20190302130A1 (en) | Haemoglobin test kit | |
| FI65676C (en) | METHODS OLAEGGNING FOER ANALYZER | |
| World Health Organization | Report on an informal consultation on quality assurance of solid phase chemistry tests | |
| János Kappelmayer | The Hungarian Society of Laboratory Medicine–serving patients for 70 years | |
| JPS58140644A (en) | Automatic analyzing apparatus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20160202 |